From Australia to China and buyouts to venture, industry participants give their perspectives on the year to come for fundraising, investments, and exits
MOUNIR GUEN, CEO AT MVISION, ON KEY TRENDS IN ASIA AND GLOBALLY: There was a habit in the early 2000s of using fundraising as a barometer for the health or activity levels in the industry. Today it is...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.